Phil Gold is the Douglas G. Cameron Professor of Medicine, and Professor of Physiology and Oncology, at McGill University. He has served as Chairman of the Department of Medicine at McGill and Physician-in-Chief at the Montreal General Hospital. He is presently the Executive Director of the Clinical Research Centre of the McGill University Health Centre.
Dr. Gold’s early research led to the discovery and definition of the Carcinoembryonic Antigen (CEA), the blood test most frequently used in the diagnosis and management of patients with cancer. For this work, other studies, and his outstanding contributions as a medical educator, he has gained national and international recognition. He has been elected to numerous prestigious organizations and has been the recipient of such outstanding awards as the Gairdner Foundation Annual International Award, the Isaak Walton Killam Award in Medicine of the Canada Council, and the National Cancer Institute of Canada R.M. Taylor Medal. He has been elected to membership in the Royal Society of Canada, the Association of American Physicians, and Mastership in the American College of Physicians. His outstanding contributions to teaching have been recognized by an award as a Teacher of Distinction from his Factulty of Medicine. He has been honored by his country, his province, his city, and his university by appointment as a Companion of the Order of Canada, an Officer of l’Ordre National du Québec, a member of the Academy of Great Montrealers; and as the recipient of the Gold Medal of the McGill University Graduate Society, respectively. He has been the Sir Arthur Sims Traveling Professor to the British Commonwealth.
Dr. Christopher Mason completed his dual B.S. in Genetics and Biochemistry (2001) from University of Wisconsin-Madison, his Ph.D. in Genetics (2006) from Yale University, and then completed dual post-doctoral training in clinical genetics (2009) at Yale Medical School, and a joint post-doctoral Fellow of Genomics, Ethics, and Law at Yale Law School (2009). He is currently an Associate Professor at Weill Cornell Medicine, with appointments at the Tri-Institutional Program on Computational Biology and Medicine between Cornell, Memorial Sloan-Kettering Cancer Center and Rockefeller University, the Sandra and Edward Meyer Cancer Center, and the Feil Family Brain and Mind Research Institute.
The Mason laboratory develops and deploys new biochemical and computational methods in functional genomics to elucidate the genetic basis of human disease and human physiology. We create and explore novel techniques in next-generation sequencing and algorithms for: tumor evolution, genome evolution, DNA and RNA modifications, and genome/epigenome engineering. We also work closely with NIST/FDA to build international standards for these methods, to ensure clinical-quality genome measurements/editing. We also work with NASA to build integrated molecular portraits of genomes, epigenomes, transcriptomes, and metagenomes for astronauts, which help establish the molecular foundations and genetic defenses for enabling long-term human space travel.
He has won the NIH’s Transformative R01 Award, the Pershing Square Sohn Cancer Research Alliance Young Investigator award, the Hirschl-Weill-Caulier Career Scientist Award, the Vallee Foundation Young Investigator Award, the CDC Honor Award for Standardization of Clinical Testing, and the WorldQuant Foundation Research Scholar Award. He was named as one of the “Brilliant Ten” Scientists by Popular Science, featured as a TEDMED speaker, and called “The Genius of Genetics” by 92Y. He has >130 peer-reviewed papers that have been featured on the covers of Nature, Science, Nature Biotechnology, Nature Microbiology, Neuron, and Genome Biology and Evolution, as well as cited by the U.S. District Court and U.S. Supreme Court. His work has also appeared on the covers of the Wall Street Journal, TIME, LA Times, New York Times, and across many media (ABC, NBC, CBC, CBS, Fox, CNN, PBS, NASA, NatGeo). He has co-founded three biotechnology start-up companies and serves as an advisor to many others. He lives with his daughter and wife in Brooklyn, NY.
Karl served his country for 27-years as a Surface Warfare Officer in the U.S. Navy. Karl was a Congressional Appropriations advisor to the Secretary of the Navy, Chief of Naval Operations and served as military liaison staff to Rep, C.W. Bill Young (R-FL), Chairman of the House Defense Appropriations Subcommittee. His military service included operational tours in command of a Destroyer Squadron based in Bahrain and an Arleigh Burke class destroyer home ported in Norfolk, VA. Mr. Van Deusen earned his B.A. in history from Marquette University, and also holds M.A. degrees in national security affairs and strategic studies from the Naval Postgraduate School, Monterey, CA and the Naval War College, Newport, RI.
Doug joined the Anaheim Ducks™/® in 2007. Prior to that, Doug was the Head Equipment Manager for the Washington Capitals™/® from 1983 to 2006. Doug also served Team USA at the 2002 Winter Olympics in Salt Lake City as well as the 1997 World Hockey Championships in Finland. In 1999, Doug was the head Equipment Manager for the NHL® All Star game in Tampa. A past president of the Society of Professional Hockey Equipment Managers, Doug holds a Bachelor of Science degree in human and physical education.
Gordon "Red" Batty has been the Head Equipment Manager for the Green Bay Packers™/® for the past 24 seasons. Prior to joining the Packers™/®, Red worked in the same capacity for 13 seasons with the Houston Oilers™/®. Long regarded as one of the best in the business, Red was named the National Football League "Equipment Manager of the Year" in 2002. He was a member of the Grey Cup champion Montreal Alouettes™/® in 1974 and 1977 as well as a Super Bowl champion with the Packers™/® in 1997 and 2011.